Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3

被引:111
|
作者
Kneitz, Burkhard [1 ]
Krebs, Markus [1 ]
Kalogirou, Charis [1 ]
Schubert, Maria [1 ,5 ]
Joniau, Steven [8 ]
van Poppel, Hein [8 ]
Lerut, Evelyne [9 ]
Kneitz, Susanne [3 ]
Scholz, Claus Juergen [2 ]
Stroebel, Philipp [6 ]
Gessler, Manfred [4 ]
Riedmiller, Hubertus [1 ]
Spahn, Martin [1 ,7 ]
机构
[1] Univ Wurzburg, Univ Hosp Wuerzburg, Dept Urol & Paediat Urol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Univ Hosp Wuerzburg, IZKF Lab Microarray Applicat, D-97080 Wurzburg, Germany
[3] Univ Wurzburg, Dept Physiol Chem 1, D-97080 Wurzburg, Germany
[4] Univ Wurzburg, Dept Dev Biochem, Bioctr, D-97080 Wurzburg, Germany
[5] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97080 Wurzburg, Germany
[6] Univ Hosp Gottingen, Dept Pathol, Gottingen, Germany
[7] Univ Hosp Bern, Inselspital, Dept Urol, CH-3010 Bern, Switzerland
[8] Univ Hosp Leuven, Dept Urol, Louvain, Belgium
[9] Univ Hosp Leuven, Dept Pathol, Louvain, Belgium
关键词
IFN-GAMMA; RADICAL PROSTATECTOMY; CYTOKINE SIGNALING-3; MICRORNA EXPRESSION; ESOPHAGEAL CANCERS; GROWTH-INHIBITION; STAT3; PROGRESSION; MELANOMA; OVEREXPRESSION;
D O I
10.1158/0008-5472.CAN-13-1606
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A lack of reliably informative biomarkers to distinguish indolent and lethal prostate cancer is one reason this disease is overtreated. miR-221 has been suggested as a biomarker in high-risk prostate cancer, but there is insufficient evidence of its potential utility. Here we report that miR-221 is an independent predictor for cancer-related death, extending and validating earlier findings. By mechanistic investigations we showed that miR-221 regulates cell growth, invasiveness, and apoptosis in prostate cancer at least partially via STAT1/STAT3-mediated activation of the JAK/STAT signaling pathway. miR-221 directly inhibits the expression of SOCS3 and IRF2, two oncogenes that negatively regulate this signaling pathway. miR-221 expression sensitized prostate cancer cells for IFN-gamma-mediated growth inhibition. Our findings suggest that miR-221 offers a novel prognostic biomarker and therapeutic target in high-risk prostate cancer. (C) 2014 AACR.
引用
收藏
页码:2591 / 2603
页数:13
相关论文
共 50 条
  • [1] The biomarker miR-221 regulates STAT1 signaling in prostate cancer by targeting IRF2
    Spahn, M.
    Krebs, M.
    Schubert, M.
    Riedmiller, H.
    Kneitz, B.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E844 - E844
  • [2] THE BIOMARKER MIR-221 REGULATES STAT1 SIGNALING IN PROSTATE CANCER BY TARGETING IRF2
    Spahn, Martin
    Krebs, Markus
    Schubert, Maria
    Riedmiller, Hubertus
    Kneitz, Burkhard
    JOURNAL OF UROLOGY, 2012, 187 (04): : E535 - E536
  • [3] MiR-221 inhibits proliferation of pancreatic cancer cells via down regulation of SOCS3
    Xie, J.
    Wen, J-T.
    Xue, X-J.
    Zhang, K-P.
    Wang, X-Z.
    Cheng, H-H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (07) : 1914 - 1921
  • [4] RETRACTED: MiR-221 affects proliferation and apoptosis of gastric cancer cells through targeting SOCS3 (Retracted Article)
    Zhou, Q. -Y.
    Peng, P. -L.
    Xu, Y. -H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (21) : 9427 - 9435
  • [5] miR-221 regulates proliferation, invasion, apoptosis and progression of prostate cancer cells by modulating E-cadherin/Wnt/8 catenin axis
    Baruah, Meghna M.
    Sharma, Neeti
    ADVANCES IN CANCER BIOLOGY-METASTASIS, 2021, 2
  • [6] DOWNREGULATION OF MIR-221 IS A STRONG AND INDEPENDENT PREDICTOR OF CLINICAL PROGRESSION AND CSS IN HIGH-RISK PROSTATE CANCER
    Spahn, M.
    Joniau, S.
    Kneitz, S.
    Scholz, C. J.
    Schubert, M.
    Kalogiru, C.
    Lerut, E.
    Stroebel, P.
    Van Poppel, H.
    Riedmiller, H.
    Kneitz, B.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 238 - 239
  • [7] miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1
    Krebs, Markus
    Behrmann, Christoph
    Kalogirou, Charis
    Sokolakis, Ioannis
    Kneitz, Susanne
    Kruithof-de Julio, Marianna
    Zoni, Eugenio
    Rech, Anne
    Schilling, Bastian
    Kuebler, Hubert
    Spahn, Martin
    Kneitz, Burkhard
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [8] RETRACTED: MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3 (Retracted Article)
    Liu, H. -P.
    Zhang, Y.
    Liu, Z. -T.
    Qi, H.
    Zheng, X. -M.
    Qi, L. -H.
    Wang, J. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (21) : 9286 - 9294
  • [9] RETRACTED: MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3 (Retracted Article)
    Wang, J.
    Guo, J.
    Fan, H.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (12) : 5168 - 5175
  • [10] MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3 (vol 23, pg 9286, 2019)
    Liu, H. -P.
    Zhang, Y.
    Liu, Z. -T.
    Qi, H.
    Zheng, X. -M.
    Qi, L. -H.
    Wang, J. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (15) : 7914 - 7914